Viewing Study NCT06220318


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2025-12-26 @ 3:58 AM
Study NCT ID: NCT06220318
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-28
First Post: 2024-01-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors
Sponsor: Fujian Haixi Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module